BIP
CSCI

Brandes Investment Partners’s COSCIENS Biopharma Inc. Common Stock CSCI Stock Holding History

Brandes Investment Partners’s Portfolio CSCI Stock Details CSCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-340
Closed -$80K – 155
2017
Q4 		$80K Buy
+340
New +$70.8K ﹤0.01% 146

Other funds holding CSCI

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
CG
Cutler Group San Francisco, California $307M AUM 45.11% 1-Year Est. Return

Brandes Investment Partners's CSCI Position: Q1 2018 in Review

Brandes Investment Partners sold out of COSCIENS Biopharma Inc. Common Stock (CSCI) in Q1 2018, closing a stake of 340 shares — an estimated $80K sold.

Brandes Investment Partners first reported a position in CSCI in Q4 2017 and held it in 1 quarter. The position peaked at $80K in Q4 2017. 16 funds tracked by Wall St. Rank hold CSCI as of Q1 2018.

  • Brandes Investment Partners reported no remaining COSCIENS Biopharma Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • Brandes Investment Partners sold 340 COSCIENS Biopharma Inc. Common Stock shares in Q1 2018, an estimated $80K.
  • Brandes Investment Partners first reported a position in COSCIENS Biopharma Inc. Common Stock in Q4 2017 and held it in 1 quarter.
  • Brandes Investment Partners's COSCIENS Biopharma Inc. Common Stock position peaked at $80K in Q4 2017.
  • 16 funds tracked by Wall St. Rank held COSCIENS Biopharma Inc. Common Stock as of Q1 2018.

Based on Brandes Investment Partners's 13F filing for Q1 2018, filed 15 May 2018.